Insight - Oct. 6th, 2020
Insight
•
07-Oct-2020
Today on Insight, John and Josh Rosenstern discuss the COVID19 treatment of President Trump, and how it has come under fire. Brother Josh says the FDA has given an expedited approval of Remdesiver and dexamethasone which the President was given. The Rosenstern’s discuss the COVID19 concerns that put people in a high risk group with regards to age, weight and other high risk categories. Brother Josh addresses the addictions that have come about for people going through this current pandemic with regards to fear. He believes obesity has increased. No matter what the problem, the Rosenstern's remind that Jesus Christ can break the chains of all bondages. Brother Josh encourages all believers to be about the Lord’s business, praying and spreading the good news of the Gospel, and the wisdom will come from the Lord.
Up Next in Insight
-
Insight Aug. 22nd, 2019
Today, John and Josh Rosenstern address the current immigration crisis on the American southern border and explain the problems in the American immigration system that have facilitated this situation.
-
Insight - Sep. 26th, 2023
The United States is still the land of opportunity. Today on Insight, John and Josh Rosenstern discuss the complications of the illegal immigration crisis going on at America’s Southern border. There are many obvious short-term issues, looking at lawlessness and the lack of resources to care fo...
-
Insight - September 3rd, 2025
Today on Insight, John Rosenstern discusses recent survey results from the Journal of Psychiatric research on abortion. Results show that women who have had an abortion are at a greater risk of developing a mental health issue. The study sample was large, and data was gathered over a long perio...
